Garrison LP - Search Results

1

Potential cost-effectiveness of universal access to modern contraceptives in Uganda.

Babigumira JB, Stergachis A, Veenstra DL, Gardner JS, Ngonzi J, Mukasa-Kivunike P, Garrison LP. Babigumira JB, et al. Among authors: garrison lp. PLoS One. 2012;7(2):e30735. doi: 10.1371/journal.pone.0030735. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22363480 Free PMC article.

2

Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests.

Ramsey SD, Veenstra DL, Garrison LP Jr, Carlson R, Billings P, Carlson J, Sullivan SD. Ramsey SD, et al. Among authors: garrison lp jr. Am J Manag Care. 2006 Apr;12(4):197-202. Am J Manag Care. 2006. PMID: 16610921 Free article.

3

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer.

Garrison LP Jr, Lubeck D, Lalla D, Paton V, Dueck A, Perez EA. Garrison LP Jr, et al. Cancer. 2007 Aug 1;110(3):489-98. doi: 10.1002/cncr.22806. Cancer. 2007. PMID: 17592827 Free article.

4

A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications.

Garrison LP Jr, Carlson RJ, Carlson JJ, Kuszler PC, Meckley LM, Veenstra DL. Garrison LP Jr, et al. Drug Metab Rev. 2008;40(2):377-401. doi: 10.1080/03602530801952500. Drug Metab Rev. 2008. PMID: 18464050 Review.

5

The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer.

Carlson JJ, Garrison LP, Ramsey SD, Veenstra DL. Carlson JJ, et al. Among authors: garrison lp. Value Health. 2009 Jan-Feb;12(1):20-7. doi: 10.1111/j.1524-4733.2008.00415.x. Epub 2008 Jul 18. Value Health. 2009. PMID: 18647257 Free article.

6

Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis.

Carlson JJ, Garrison LP, Ramsey SD, Veenstra DL. Carlson JJ, et al. Among authors: garrison lp. J Cancer Res Clin Oncol. 2009 Nov;135(11):1483-93. doi: 10.1007/s00432-009-0595-3. Epub 2009 May 9. J Cancer Res Clin Oncol. 2009. PMID: 19430813 Review.

7

The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancer.

Garrison LP Jr, Veenstra DL. Garrison LP Jr, et al. Value Health. 2009 Nov-Dec;12(8):1118-23. doi: 10.1111/j.1524-4733.2009.00572.x. Epub 2009 Jul 14. Value Health. 2009. PMID: 19624617 Free article.

8

Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda.

Babigumira JB, Castelnuovo B, Lamorde M, Kambugu A, Stergachis A, Easterbrook P, Garrison LP. Babigumira JB, et al. Among authors: garrison lp. BMC Health Serv Res. 2009 Oct 21;9:192. doi: 10.1186/1472-6963-9-192. BMC Health Serv Res. 2009. PMID: 19845963 Free PMC article.

9

Preference values associated with stage III colon cancer and adjuvant chemotherapy.

Best JH, Garrison LP, Hollingworth W, Ramsey SD, Veenstra DL. Best JH, et al. Among authors: garrison lp. Qual Life Res. 2010 Apr;19(3):391-400. doi: 10.1007/s11136-010-9589-5. Qual Life Res. 2010. PMID: 20084462

10

Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers.

Carlson JJ, Sullivan SD, Garrison LP, Neumann PJ, Veenstra DL. Carlson JJ, et al. Among authors: garrison lp. Health Policy. 2010 Aug;96(3):179-90. doi: 10.1016/j.healthpol.2010.02.005. Epub 2010 Mar 11. Health Policy. 2010. PMID: 20226559 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters